Bio News

The National Institute of Animal Science, part of the Rural Development Administration, and a research team at Jeonbuk National University jointly developed a technology to produce exosomes derived from canine stem cells.
The research team modified canine stem cells to produce higher levels of miRNA-3962, a substance that reduces inflammation.
In cell experiments, the exosomes lowered markers of allergic reactions, and the National Institute of Animal Science filed a related patent application.

Biobook Team
biobookmedia@biobook.co.krEuropean CHMP Recommends Approval of AstraZeneca’s Blood Pressure Drug Baxpendi
Novo Seeks U.S. and European Approval for Sickle Cell Drug Etavopivat
Rezolute Meets Primary Endpoint in Phase 3 Trial for Tumor Hyperinsulinism; FDA Meeting Ahead
Five Brain Disease Startups Raise $450 Million in a Few Weeks
American Cancer Society Revises Prostate Cancer Screening Guidelines for First Time in 16 Years
Shin Dong-kook Raises Stake in Hanmi Science to 30.18% With Over-the-Counter Purchase of 1.38 Million Shares